The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09A | Central nervous system | |
| 4 | V09AX | Other central nervous system diagnostic radiopharmaceuticals |
| Code | Title | |
|---|---|---|
| V09AX01 | Indium (111In) pentetic acid | |
| V09AX04 | ||
| V09AX05 | ||
| V09AX06 | ||
| V09AX07 |
| Active Ingredient | Description | |
|---|---|---|
| Florbetaben ¹⁸F |
Florbetaben ¹⁸F binds to β-amyloid neuritic plaques in the brain. It is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. |
|
| Florbetapir ¹⁸F |
Florbetapir ¹⁸F binds to β-amyloid plaques and the ¹⁸F isotope produces a positron signal that is detected by a PET scanner. Florbetapir ¹⁸F is indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline. |
|
| Flutemetamol ¹⁸F |
Flutemetamol ¹⁸F binds to β-amyloid neuritic plaques in the brain. It is a radiopharmaceutical medicinal product indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. VIZAMYL should be used in conjunction with a clinical evaluation. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| AMYVID Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| NEURACEQ Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| VIZAMYL Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
